Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Trading Statement

31 Mar 2021 12:16

RNS Number : 1464U
Ceiba Investments Limited
31 March 2021
 

31 March 2021

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

TRADING UPDATE

Successful issue of €25 million Senior Unsecured Convertible Bonds 2026

 

 

CEIBA Investments Limited ("CEIBA" or the "Company"), the largest listed international company solely dedicated to investing in Cuba, with interests in Cuba's commercial and tourism real estate sectors, is pleased to announce the successful completion of a €25,000,000, 10%, senior unsecured convertible bond issue due for repayment on 31 March 2026 (the "Bonds"). The conversion price of the Bonds is equal to the (unaudited) net asset value per ordinary share as at 30 June 2020 (104.3 pence). The Bonds were issued on 31 March 2021 and will be admitted to The International Stock Exchange (TISE), Guernsey. The ISIN number of the Bonds is GG00BMV37C27.

 

The principal purpose of issuing the Bonds is to provide finance that allows for the completion of the construction of the Meliá Trinidad Península a 400 room, beachfront hotel, in Trinidad, Cuba, but the proceeds of the Bonds may also be used for investment in the logistics warehouse development project of Grupo B.M. Interinvest Technologies Mariel S.L., for general corporate purposes, and for other commercial opportunities when they arise. The Bonds are not expected to be used to support any operating costs of the Company due to the strong, continuing earnings performance of the Company's largest investment, the Miramar Trade Centre office complex.

 

The issue was increased from €20 million to €25 million due to strong investor demand and remained oversubscribed by existing and new investors. It is the first major international fundraise into Cuba since the announcement of Cuba's monetary reforms in December 2020. The total cost of the issue was less than 1.30% including broker, legal, registration and any other fees payable by the Company. Neither the Company nor any of its subsidiaries have any other third-party debt financing apart from the Bonds.

 

John Herring, Chairman of the Board of Directors of CEIBA, commented:

 

"We are really encouraged to have received this support from both our existing shareholder base and new investors. In turn, we are very pleased to be able to support Cuba and its economy, through the completion of this unique hotel, especially given the current challenging and uncertain Covid-impacted environment."

 

"Mutual respect, engagement, confidence and economic growth are essential ingredients for the country to move forward, and it would appear that by carrying out monetary reforms and broadening the legal framework for the private sector, Cuba is taking big steps in the right direction. The funding sourced to complete the Meliá Trinidad Península is another small step towards the future."

 

""CEIBA is very well positioned to continue its leading role in Cuba's foreign direct investment sector." 

Sebastiaan Berger, Fund Manager of Aberdeen Standard Investments and CEO of CEIBA, commented:

 

"We are very excited that the funding to ensure the timely completion of this state-of-the-art hotel in Trinidad has now been secured so that it can be added to the Company's high quality investment portfolio of Cuban mixed real estate assets."

 

"Investors seem to understand that a window of opportunity is opening and that there are real chances that both tackling the Covid-19 pandemic and the US-Cuban relationship will improve in the foreseeable future."

 

Background

 

During 2021, CEIBA will celebrate the 25th anniversary of its Cuban investments and operations. The Company was the first Cuba dedicated investment trust to be listed on the Specialist Fund Segment of the London Stock Exchange following a successful IPO that took place on 18 October 2018. Its principal investments are in the Miramar Trade Centre, Havana's principal business centre, the hotel Meliá Habana hotel (in Havana), the Meliá Las Américas, Meliá Varadero and Sol Palmeras hotels (in Varadero), the Meliá Trinidad Península hotel (in Trinidad) and an industrial logistics complex development in the Special Development Zone of Mariel. The Company's 2020 Financial Statements are scheduled to be published in April 2021.

 

 

END OF ANNOUNCEMENT

 

For further information, please contact:

 

Aberdeen Standard Fund Managers Limited Tel: +44 (0)20 7463 6000

Sebastiaan Berger / Evan Bruce-Gardyne 

N+1 Singer Tel: +44 (0)20 7496 3000

James Maxwell / James Moat (Corporate Finance)

James Waterlow (Sales)

 

JTC Fund Solutions (Guernsey) Limited Tel: +44 (0)1481 702400

 

www.ceibalimited.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGFFMMKGMZM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.